top of page
Search

Pancreatic Cancer & Cysts — MRCP Part 1

TL;DR

Pancreatic cancer & cystic lesions are high-yield topics for MRCP Part 1, commonly tested through imaging findings, tumour markers, and clinical patterns. Focus on differentiating malignant cysts from benign lesions, recognising red-flag symptoms, and interpreting CT/EUS findings. A few classic exam clues—like painless jaundice and the double duct sign—can secure easy marks.


Why this matters

Pancreatic pathology is a favourite testing area in MRCP Part 1, bridging gastroenterology, oncology, and radiology. Questions often require rapid differentiation between pancreatic cancer and cystic lesions using subtle clinical and imaging cues.

A structured approach—starting with the MRCP Part 1 overview and practising via Free MRCP MCQs—can significantly improve accuracy in this topic.


Core sections

1. Pancreatic Cancer: The Big Picture

  • Most common type: Pancreatic ductal adenocarcinoma (~90%)

  • Risk factors: Smoking, chronic pancreatitis, diabetes, obesity

  • Genetic associations: BRCA2, Lynch syndrome

  • Most common location: Head of pancreas

Classic presentation:

  • Painless obstructive jaundice

  • Weight loss

  • Dark urine, pale stools

  • Courvoisier’s sign (palpable gallbladder)

👉 Exam pearl: Painless jaundice = pancreatic cancer until proven otherwise

2. Key Investigations

  • First-line imaging: Contrast-enhanced CT scan

  • Tumour marker: CA 19-9

    • Useful for monitoring

    • Not diagnostic

  • Definitive test: Endoscopic ultrasound (EUS) + biopsy

👉 MRCP tip: Always correlate CA 19-9 with imaging—never interpret in isolation.

3. Cystic Lesions of the Pancreas

These frequently appear in image-based questions.

Lesion Type

Typical Features

Malignancy Risk

Serous cystadenoma

Microcystic, central scar

Low

Mucinous cystadenoma

Female, body/tail

High

IPMN

Dilated pancreatic duct

Variable

Pseudocyst

Post-pancreatitis, no epithelial lining

None

👉 Key differentiation: History of pancreatitis strongly suggests pseudocyst.

4. Five Most Tested Subtopics

  1. Obstructive vs hepatocellular jaundice

  2. Interpretation of CA 19-9

  3. Differentiation of mucinous cysts vs IPMN

  4. Pseudocyst vs neoplastic cyst

  5. Indications for surgery vs surveillance

5. Imaging Clues You Must Know

  • Double duct sign → pancreatic head carcinoma

  • Central stellate scar → serous cystadenoma

  • Main duct dilation → IPMN

  • Thick wall with debris → pseudocyst

👉 Exam tip: Radiology descriptions often give away the diagnosis—train your pattern recognition.

6. Management Principles

Pancreatic cancer:

  • Resectable → Whipple procedure (pancreaticoduodenectomy)

  • Locally advanced → chemotherapy ± radiotherapy

  • Metastatic → palliative care

Cystic lesions:

  • Low-risk → surveillance

  • High-risk (e.g. mucinous features, size >3 cm, nodules) → surgery

7. High-Yield Summary List (Exam Gold)

  1. Painless jaundice suggests pancreatic head cancer

  2. CA 19-9 is not diagnostic

  3. Smoking is the strongest modifiable risk factor

  4. Pseudocysts follow pancreatitis

  5. Mucinous cysts have malignant potential

  6. IPMN involves pancreatic ducts

  7. Double duct sign is highly suggestive of malignancy

  8. CT is first-line imaging

  9. EUS is best for biopsy

  10. Weight loss is a red flag


Practical examples / mini-cases

MCQ: A 64-year-old man presents with painless jaundice and unintentional weight loss. CT shows a pancreatic head mass with dilation of both the common bile duct and pancreatic duct.

What is the most likely diagnosis?

A. Chronic pancreatitisB. Pancreatic adenocarcinomaC. IPMND. Pancreatic pseudocyst

Answer: B. Pancreatic adenocarcinoma

Explanation: The “double duct sign” is highly suggestive of pancreatic head carcinoma. The absence of pain and presence of weight loss further support malignancy rather than inflammatory causes.


Medical student preparing pancreatic cancer and cystic lesions for MRCP Part 1 exam revision

Common pitfalls (5 bullets)

  • Confusing pseudocysts with cystic neoplasms

  • Over-relying on CA 19-9 for diagnosis

  • Missing malignant potential in mucinous cysts

  • Ignoring weight loss as a red flag

  • Misinterpreting imaging patterns


Practical study-tip checklist

  • ✔ Learn cystic lesions using comparison tables

  • ✔ Focus on imaging-based questions

  • ✔ Practise daily via Free MRCP MCQs

  • ✔ Revise tumour markers and their limitations

  • ✔ Attempt full-length exams using Start a mock test


FAQs

1. Is CA 19-9 diagnostic for pancreatic cancer?

No. It is a supportive marker and may be elevated in benign conditions such as cholestasis. Always interpret alongside imaging.

2. How do you differentiate pseudocyst from cystic tumour?

A history of pancreatitis suggests pseudocyst. Tumours have structured walls, septations, and malignant potential.

3. What is the most common presentation of pancreatic cancer?

Painless obstructive jaundice, especially in cancers of the pancreatic head.

4. Which pancreatic cyst has the highest malignancy risk?

Mucinous cystic neoplasms have significant malignant potential and require careful evaluation.

5. What is the best investigation for pancreatic lesions?

Contrast-enhanced CT is first-line; EUS with biopsy provides definitive diagnosis.


Ready to start?

To master pancreatic pathology for MRCP Part 1, combine conceptual clarity with exam-style practice. Begin with the MRCP Part 1 overview, reinforce learning through Free MRCP MCQs, and simulate real exam conditions using a Start a mock test.


Sources

 
 
 

Comments

bottom of page